# SpecGx, LLC – FDA Inspection, Sep 18, 2023

Source: https://www.keypedia.com/records/fda_inspections/specgx-llc/3e43114c-0b19-49da-9cf2-9cc14aa3651d
Source feed: FDA_Inspections

> FDA inspection 1220234 of SpecGx, LLC, September 18, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220234
- Company Name: SpecGx, LLC
- Inspection Date: 2023-09-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1316986 - 2026-05-07
- FDA Inspection 1122446 - 2020-03-16
- FDA Inspection 1085155 - 2019-03-06
- FDA Inspection 1077155 - 2019-01-15
- FDA Inspection 1039082 - 2018-01-26

## Related Officers

- [Investigator](https://www.keypedia.com/people/monica-e-murie/2db840df-d69f-4def-9830-fd461bea5507)
- [FDA Associated Person](https://www.keypedia.com/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)

Company: https://www.keypedia.com/companies/specgx-llc/ee069c18-3128-4bbe-9c13-768b4837810f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
